420 with CNW – EU Parliament Votes to Support Medical Cannabis

On Wednesday (February 13), the European Union Parliament passed a resolution that will help to advance research into medical cannabis within the EU. This resolution comes hot on the heels of a recommendation by the World Health Organization (WHO) to reschedule cannabis internationally.

While the resolution passed in the EU Parliament isn’t binding, it provides encouragement to EU member states to increase their citizens’ access to medical marijuana. The resolution also calls on member countries to prioritize research and clinical studies on marijuana.

This resolution passed by the EU Parliament provides yet another voice in support of medical marijuana. The World Health Organization also recommended that cannabis be rescheduled in recognition of its therapeutic potential while also being aware that the drug can be addictive. A final vote is expected in March to cement the position of the UN on the recommendations made by the WHO expert committee that studied the matter at great length.

The EU resolution also goes further to call on member states to set standards for all non-pharmaceutical cannabis products in a bid to protect consumers.

Member states were also called upon to address all the legal, cultural, regulatory and financial barriers that have stood in the way of scientific research on marijuana and its medicinal uses. To put this appeal into context, consider the U.S. federal government’s laws on marijuana. Those laws make it hard for researchers to conduct any meaningful studies since cannabis is federally illegal and isn’t recognized as having any therapeutic value.

Additionally, only one cultivator (based in Mississippi) is mandated to provide all the cannabis needed for any approved research in the U.S. The cannabis from this facility is notorious for its poor quality (if researchers can manage to secure that marijuana in the first place). Such barriers have made the U.S. to lag behind in cannabis research. The EU resolution seeks to fix such problems amongst EU member states.

The members of the European Parliament also agreed that it was necessary to establish case-specific therapies for the medicinal use of cannabis. For example, does someone with chronic pain require the same concentration of THC and CBD (among other ingredients) as another person who wants to use medical cannabis to treat or manage insomnia? Scientific research should be able to answer such questions, according to the EU Parliament.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and Youngevity International, Inc. (NASDAQ: YGYI) welcome the decisions made by the EU Parliament and the World Health organization regarding the medical benefits of marijuana.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Four Things You May Not Know about Cannabis Jobs in the US

Your mind may immediately go to the rate at which different states are legalizing marijuana when the cannabis industry in the U.S. is mentioned. However, there is so much that many people don’t know about the job market in the U.S. cannabis industry. Here are four facts you most likely didn’t know about employment in the cannabis industry in the U.S.

Hiring Has Increased By 76 Percent

According to a study conducted by Glassdoor, the number of available jobs in the cannabis industry in the U.S. has increased by 76 percent when compared to the number of jobs that were available in 2017. Additionally, the second half of the year saw the biggest jump in the number of cannabis jobs advertised throughout the country.

Cannabis Jobs Have Attractive Salaries

Contrary to what many people may think, jobs in the cannabis industry don’t pay minimum wage. The Glassdoor research revealed that the average base salary for the jobs advertised in the cannabis industry was $58,511 a year. That figure may not be glamorous on its own, but it takes on greater significance when you realize that the median base salary across the U.S. in general is approximately 11 percent lower than the median base salary of the cannabis industry jobs advertised. In fact, slightly more than 30 percent of the cannabis industry jobs advertised paid more than $70,000 as base salary. In short, the cannabis industry may be among the best-paying industries in the country!

Many of the Top Employment Destinations Aren’t Where Recreational Cannabis is Legal

One may be tempted to think that the greatest number of jobs are to be found in locations where recreational cannabis was legalized. This is only partially true because the Glassdoor data shows that cities in California ranked highest among the top destinations for marijuana industry jobs.

However, cities in states where only medical marijuana is legal also pulled their weight as top cannabis employment destinations. For example, New York City was fourth on the list of the top 15 cannabis employment destinations while Chicago was seventh on that list.

Most of the Top Employers Are Traded Publicly

It is possible for casual observers to imagine that only Canadian cannabis companies are publicly traded. However, while the Canadian companies get the lion’s share of publicity, American marijuana companies are also traded on different stock exchanges. For example, Green Thumb Industries is traded on Nasdaq and it was the top employer in the cannabis industry. Others are MedMen Enterprises and Truelive.

While the findings of the study were only based on the jobs advertised on Glassdoor, the general idea is that the cannabis industry is growing fast since employers can only take on new hires once those employers are sure of sustainable growth to justify the cost of additional employees. The Glassdoor research is therefore good news to the marijuana industry, including Youngevity International, Inc. (NASDAQ: YGYI) and VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF).

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com